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The rotavirus NSP4 protein is cytotoxic when transiently expressed in cells and is capable of inducing secretory
diarrhea in neonatal mice. NSP4 consists of 175 amino acids, and sequences important for its toxic effects have been
mapped to the carboxy-terminal half of the protein. In this report, we compared NSP4-encoding nucleotide sequences
recovered from cell lines engineered to express NSP4 from human rotavirus strain Wa with NSP4 sequences recovered
from cells persistently infected with either Wa or simian rotavirus strain SA11. In cells stably transfected with Wa NSP4,
we found that proline138 was changed to either serine or threonine. However, in cells persistently infected with SA11, we
found that phenylalanine33 was changed to leucine, and in cells persistently infected with Wa, no changes were observed
in NSP4. Expression of Wa NSP4 in Caco-2 cells resulted in increased cell-doubling times and decreased cell viability
in comparison to cells expressing NSP4–serine138 or NSP4–threonine138. This result suggests that sequence polymor-
phism at residue 138 in Wa NSP4 influences the cytotoxicity of the protein. Therefore, mutations in the carboxy-terminal
half of NSP4 are selected when NSP4 is expressed in cells in the absence of other viral proteins, but not in the context
of viral replication. These findings suggest that cytotoxic functions of NSP4 are not operant during natural rotavirus
infection. © 2000 Academic Press
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Rotaviruses are nonenveloped viruses that cause se-
vere diarrhea in infants and young children (Kapikian and
Chanock, 1996; Estes, 1996). Rotavirus nonstructural pro-
tein NSP4 is a multifunctional, membrane-spanning pro-
tein of 175 amino acids hypothesized to play an impor-
tant role in the pathogenesis of rotavirus-induced gas-
troenteritis. Studies using purified NSP4 from certain
animal rotaviruses suggest that NSP4 serves as a cyto-
toxin and enterotoxin (Ball et al., 1996; Estes, 1996; Zhang
et al., 1998). Expression of simian rotavirus SA11 NSP4 in
MA104 cells results in cytotoxicity by altering membrane
permeability (Newton et al., 1997). Analysis of mutant
forms of NSP4 indicates that a membrane-proximal re-
gion of the protein corresponding to amino acid residues
55 to 72 is responsible for this cytotoxic effect. Baculo-
virus-expressed SA11 NSP4 and a peptide correspond-
ing to NSP4 amino acids 114 to 135 are potent entero-
toxins in mice (Ball et al., 1996). These findings have
been used to support the hypothesis that NSP4 serves
as a rotavirus virulence determinant.
Despite the toxic activities of NSP4, there appear to be
few mutations in either the cytotoxic or the enterotoxic
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125domains of NSP4 derived from attenuated human rota-
virus strains. Ward et al. (1997) showed that attenuated
strain 89-12 has a single amino acid change at residue
45 within the amino-terminal half of NSP4, but this
change also was noted in human rotavirus isolates as-
sociated with symptomatic disease. Chang et al. (1999)
howed that attenuated strains of human rotavirus Wa
ad three mutations located within the amino-terminal 34
mino acids of NSP4. These studies suggest that during
he replication of human rotaviruses, mutations are not
elected in the carboxy-terminal half of NSP4, which
ontains sequences important for its enterotoxic activi-
ies.
The absence of mutations in the carboxy-terminal half
f NSP4 in attenuated human rotavirus strains led us to
ypothesize that the cytotoxicity of NSP4 is suppressed
uring viral infection. To test this hypothesis, we deter-
ined whether the cytotoxic effects of NSP4 are depen-
ent on the context of its expression. We compared
SP4-encoding nucleotide sequences derived from in-
ependent cell lines engineered to constitutively express
a NSP4 with sequences of NSP4 derived from cells
ersistently infected with either Wa or SA11. The results
emonstrate that mutations are selected in a region of
SP4 important for toxicity during its stable expression
n the absence of other rotavirus proteins but not during
ersistent infection. These findings suggest that the cy-
otoxicity of NSP4 is suppressed in the context of viral
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126 KRISHNA MOHAN, DERMODY, AND ATREYAinfection and therefore may not contribute directly to
rotavirus virulence.
RESULTS
Constitutive expression of NSP4 in Caco-2 cells
To determine whether the cytotoxicity of NSP4 results
in the selection of mutations during its constitutive ex-
pression in cells, we engineered plasmids encoding ei-
ther NSP4 appended with an HA epitope tag (NSP4–HA)
or a truncated form of NSP4 lacking the first translation
initiation codon (NSP4–DATG) as a control (Fig. 1). Each
plasmid also contained a gene encoding neomycin re-
sistance to facilitate selection of transfected cells with
the antibiotic G418. The HA epitope tag was used to
allow detection of NSP4 even in the event of mutations
that might alter the native structure of the protein. The
plasmid constructs were tested for NSP4 expression in
transcription-coupled translation reactions in vitro (Fig.
A). After confirming that NSP4–HA was capable of ex-
ressing NSP4 and that NSP4–DATG was not, Caco-2
ells were transfected with each plasmid in two inde-
endent transfection experiments, designated I and II.
Two weeks after transfection, 9 cell foci were evident
rom cells transfected with NSP4–DATG (4 from experi-
ent I and 5 from experiment II), and 11 cell foci were
vident from cells transfected with NSP4–HA (5 from
xperiment I and 6 from experiment II). These foci were
ropagated independently and tested for expression of
FIG. 1. Plasmid constructs used to express rotavirus NSP4. An NSP4-e
pCR3.1 to yield pCR–NSP4. The NSP4-encoding cDNA was appended w
base pairs) or truncated to remove the initiation codon to generate NSP
at the 59 end and XhoI at the 39 end. A bacteriophage T7 RNA polymera
promoter (Pcmv) for mammalian expression, a neomycin-resistance gen
for selection in bacteria, and a multiple-cloning site (MCS) are indicatSP4 mRNA and protein. Eight of 9 NSP4–DATG and 10
f 11 NSP4–HA foci were found to express RNA of theappropriate size (Fig. 2B). All 10 samples expressing
NSP4–HA mRNA also had detectable expression of
NSP4 protein as determined by immunoblot analysis
using an HA-epitope-specific antibody (Fig. 2C) and im-
munoprecipitation using NSP4-specific monoclonal anti-
body B4-2 (Fig. 2D). The HA-epitope-specific antibody
detected only the fully glycosylated form of NSP4 (Fig.
2C), whereas the NSP4-specific antibody also detected
partially glycosylated forms of the protein (Fig. 2D). NSP4
was not detected in cells transfected with NSP4–DATG
using either immunoblotting with the HA-epitope-specific
antibody or immunoprecipitation with NSP4-specific an-
tibody B4-2 (data not shown).
Constitutive expression selects mutations in the
carboxy-terminal half of NSP4
To determine whether constitutive expression of NSP4
leads to selection of mutations that might alter its cyto-
toxicity, we analyzed nucleotide sequences of NSP4-
encoding cDNAs recovered from 8 NSP4–DATG trans-
fected cell foci and 10 NSP4–HA transfected cell foci.
These sequences were compared with the NSP4-encod-
ing nucleotide sequence of parental strain Wa. As antic-
ipated, each of the NSP4–DATG-derived cDNA se-
quences were identical to the cDNA sequence encoding
parental NSP4. However, 3 of 9 NSP4–HA-derived cDNA
sequences had mutations at residue 138 in the deduced
amino acid sequence of NSP4 (Table 1). Two of the NSP4
g cDNA was generated by RT-PCR and cloned into expression plasmid
uences corresponding to an HA epitope tag to generate NSP4–HA (766
(718 base pairs). The NSP4-encoding cDNAs were cloned using NheI
oter (T7) for in vitro transcription, a cytomegalovirus RNA polymerase
) for selection in mammalian cells, an ampicillin-resistance gene (amp)ncodin
ith seq
4–DATG
se promvariant cDNA sequences recovered from foci selected
independently in experiments I and II had a proline to
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127MUTATIONS IN ROTAVIRUS ENTEROTOXIN NSP4serine138 substitution; an additional variant from experi-
ment II had a proline to threonine138 substitution.
ersistent rotavirus infection selects mutations in the
mino-terminal half of NSP4
To determine whether mutations are selected in NSP4
uring persistent rotavirus infection, we analyzed nucle-
tide sequences of NSP4-encoding cDNAs recovered
rom MA104 cells persistently infected with either Wa or
A11. We established MA104 cell cultures persistently
nfected with Wa for this study; cultures persistently in-
ected with SA11 were established in a previous study
Mrukowicz et al., 1998). RNA was extracted from cell-
FIG. 2. (A) Expression of NSP4 in vitro. The pCR–NSP4, pCR-NSP4
lysates containing [35S]methionine using a coupled transcription and tr
used to precipitate the translation products prior to electrophoresis in
and 3 correspond to translation products derived from the pCR–NSP4,
NSP4–HA (lane 3) was precipitated using the HA-specific monoclonal a
Expression of NSP4 mRNA in transfected cell foci. Total cellular RNA w
cells with either pCR–NSP4–DATG or pCR–NSP4–HA plasmid DNA an
agarose gel and stained with ethidium bromide. Duplicate transfe
transfectants from experiment I. Lanes 6–10, pCR–NSP4–DATG transfe
DNA). Lanes 12–16, pCR–NSP4–HA transfectants from experiment I. La
the expected sizes for NSP4–DATG and NSP4–HA are indicated by a
analysis. Total cellular proteins from G418-resistant cell foci were collec
n a 15% polyacrylamide gel. After electrophoresis, the gel was ele
A-specific monoclonal antibody. Protein products were detected usin
ment I. Lanes 6–11, pCR–NSP4–HA transfectants from experiment II. L
n kilodaltons are indicated on the left. (D) Detection of NSP4–HA exp
sing [35S]methionine and subjected to immunoprecipitation with NSP
eled proteins were resolved by electrophoresis in a 15% polyacrylamid
CR–NSP4–HA transfectants from experiment I. Lanes 6–11, pCR–NSP
s a control. Molecular weight markers in kilodaltons are indicated on th
igrating bands in (D) correspond to partially glycosylated forms of NSP
assage numbers.ulture supernatants obtained from the persistently in-
ected cultures at various intervals from 14 to 97 days of
t
1ersistent infection, and NSP4-encoding cDNAs were
enerated by RT-PCR. Nucleotide sequences were de-
ermined directly from the PCR products of the NSP4-
ncoding cDNAs and compared to the NSP4-encoding
equences of the corresponding parental strains (Table
). NSP4-encoding sequences recovered from the
A104 cell culture persistently infected with Wa revealed
o mutations through day 76 of culture maintenance. We
ere unable to amplify any rotavirus-specific cDNA from
he culture supernatant obtained at day 97, which sug-
ests that the persistent infection had spontaneously
ured between days 76 and 97. NSP4-encoding se-
uences recovered from the MA104 cell culture persis-
, and pCR–NSP4–HA plasmids were translated in rabbit reticulocyte
n system. A monoclonal antibody specific for the HA epitope tag was
olyacrylamide gel. The gel was dried and exposed to film. Lanes 1, 2,
SP4–DATG, and pCR–NSP4–HA plasmids, respectively. Note that only
y. Molecular weight markers in kilodaltons are indicated on the left. (B)
ated from G418-resistant cell foci selected after transfection of Caco-2
ected to NSP4-specific RT-PCR. PCR products were resolved in a 1%
xperiments are designated I and II. Lanes 1–5, pCR–NSP4–DATG
rom experiment II. Lane 11, DNA size markers (HaeIII digest of FX 174
–22, pCR–NSP4–HA transfectants from experiment II. PCR products of
(C) Detection of NSP4–HA expression in Caco-2 cells by immunoblot
er cell lysis, and samples equivalent to 30 mg of protein were resolved
tted onto a nitrocellulose membrane and immunoblotted using an
iluminescence. Lanes 1–5, pCR–NSP4–HA transfectants from exper-
, nontransfected Caco-2 cells as a control. Molecular weight markers
in Caco-2 cells by immunoprecipitation. Proteins were radiolabeled
fic monoclonal antibody B4-2. Immune complexes containing radiola-
fter electrophoresis, the gel was dried and exposed to film. Lanes 1–5,
ransfectants from experiment II. Lane 12, nontransfected Caco-2 cells
dot on the right in (C) and (D) indicates fully glycosylated NSP4. Faster
protein and RNA samples from each cell line were prepared at identical–DATG
anslatio
a 15% p
pCR–N
ntibod
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ctants f
nes 17
rrows.
ted aft
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g chem
ane 12
ression
4-speci
e gel. A
4–HA t
e left. Aently infected with SA11 revealed no mutations at days
4, 48, and 76 of culture maintenance. However, the
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128 KRISHNA MOHAN, DERMODY, AND ATREYAdeduced amino acid sequence of NSP4 recovered from
the day 97 supernatant had a single substitution, phe-
nylalanine to leucine, at position 33. This substitution
also was observed in the deduced amino acid sequence
of NSP4 from a plaque-purified virus isolated on day 144
from the culture persistently infected with SA11. These
results indicate that few mutations are selected in NSP4
during persistent infection and that the mutations ob-
served are contained in the amino-terminal half of the
protein.
Viability of cells expressing altered forms of NSP4
To determine whether cells expressing mutant forms
of NSP4 have alterations in cell-doubling times, equal
numbers of Caco-2 cells expressing parental Wa NSP4,
NSP4–serine138, NSP4–threonine138, and NSP4–DATG
ere seeded into triplicate wells of 6-well plates at a
oncentration of 8 3 103 cells per well. At 24-h intervals
following plating, cells from each well were treated with
trypsin, resuspended in 1.0 ml of culture medium, and
enumerated using a hemacytometer (Fig. 3A). The dou-
bling time of cells expressing parental NSP4 was signif-
icantly greater than that of cells expressing NSP4–
serine138, NSP4–threonine138, or NSP4–DATG (P , 0.05).
oreover, while cells expressing NSP4–serine138, NSP4–
hreonine138, or NSP4–DATG remained viable at times
greater than 96 h after plating, cells expressing parental
NSP4 became nonadherent after 96 h of incubation (Fig.
3B). These findings provide evidence that expression of
Wa NSP4 in Caco-2 cells increases cell-doubling times
T
Mutations in NSP4 Selected during
NSP4
Status Source
Amino-termin
AA 1–113
onstitutive expression Human Wa None
iral persistence Human Wa
Day 36 None
Day 60 None
Day 76 None
Day 97a None
iral persistence Simian SA11
Day 14 None
Day 48 None
Day 76 None
Day 97 F-33
Day 144 F-33
a Failed to detect any rotavirus-specific cDNA from the culture supern
etween days 76 and 97.and decreases viability and that mutations at residue 138
ameliorate these biological effects.
w
NDISCUSSION
In this study, we used independent experimental ap-
proaches to define sequence changes in NSP4 during its
expression in cells. In the first, NSP4 was constitutively
expressed in Caco-2 cells in the absence of other viral
proteins. In the second, NSP4 was expressed in the
context of persistent rotavirus infection of MA104 cells.
We hypothesized that, due to its cytotoxic activities, mu-
tations would be selected in NSP4 in both settings, and
that was indeed the case. However, our findings indicate
that sites selected for mutation in NSP4 are dependent
on the context of its expression.
Mutations in NSP4 selected during its stable expres-
sion in Caco-2 cells were found in the carboxy-terminal
half of the protein. These mutations in NSP4 were pre-
cisely targeted to a single amino acid residue, proline138,
which was changed to either serine or threonine. This
observation is of interest in light of previous work dem-
onstrating that residue 138 plays an important role in
enterotoxic activities of NSP4 derived from porcine rota-
virus strains. The capacity of purified porcine rotavirus
NSP4 to produce diarrhea after inoculation into mice is
dependent on a proline residue at position 138; substi-
tution of proline138 with serine abrogates the enterotoxic
ctivities of NSP4 (Zhang et al., 1998). Therefore, our
inding of amino acid substitutions in Wa NSP4 at posi-
ion 138 suggests that this residue also is involved in
ytotoxic activities of human rotavirus NSP4 during its
table expression in cells. In support of this contention,
Expression or Persistent Infection
Location of mutation
Mutation
Cytotoxic domain
AA 114–135
Carboxy-terminal
AA 136–175
None P-138 S-138
T-138
None None None
None None None
None None None
None None None
None None None
None None None
None None None
None None L-33
None None L-33
hich suggested that the persistent infection had spontaneously curedABLE 1
Stable
ale found that the doubling time of cells expressing Wa
SP4 was significantly greater than that of cells express-
1
r
(b) NSP
d by a
129MUTATIONS IN ROTAVIRUS ENTEROTOXIN NSP4ing Wa NSP4 with either serine138 or threonine138. Fur-
thermore, cells expressing Wa NSP4 were less viable
FIG. 3. Mutations at amino acid position 138 in NSP4 affect viability of
expressing NSP4–DATG ([2]NSP4), NSP4–serine138 (S138), NSP4–threo
03 cells per well of 6-well tissue culture plates in triplicate. Cell doubli
epresent the average of three counts at each time interval for each cel
greater than that observed for cells expressing NSP4–serine138, NSP4–th
expressing NSP4. Caco-2 cells expressing parental and mutant form
phase-contrast microscope 110 h after plating. (a) NSP4–DATG cells,
cells. Only cells expressing parental NSP4 were nonadherent, indicatethan cells expressing mutant forms of NSP4, as judged
by diminished adherence to tissue-culture plates.In contrast to the types of mutations selected in NSP4
during its stable expression, mutations in NSP4 selected
cells. (A) Doubling times of cells expressing NSP4. Caco-2 cells stably
(T138), or NSP4–proline138 (parental-type) (P138) were seeded at 8 3
monitored at 24-h intervals following plating, up to 96 h. Cell numbers
he doubling time of cells expressing NSP4–proline138 was significantly
e138, or NSP4–DATG (P , 0.05). (B) Phase contrast microscopy of cells
SP4 as indicated in (A) were photographed at 4003 using a Nikon
4–serine138 cells, (c) NSP4–threonine138 cells, and (d) NSP4–proline138
rrowheads.Caco-2
nine138
ng was
l type. T
reonin
s of Nduring persistent infection affected a single amino acid
residue in the amino-terminal half of NSP4, phenylala-
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130 KRISHNA MOHAN, DERMODY, AND ATREYAnine33, which was changed to leucine. This mutation was
bserved only after a period of 97 days of culture main-
enance and only in the persistent infection established
sing strain SA11. We found no mutations in NSP4 during
he persistent infection established with strain Wa. Dur-
ng persistent rotavirus infections of cultured cells, mu-
ations are selected in both viruses and cells that lead to
urvival of each in the context of the persistently infected
ulture (Mrukowicz et al., 1998). It is possible that muta-
ions in the amino-terminal half of NSP4 are required for
iruses and cells to coevolve during some cases of
ersistent infection.
Mutations in the amino-terminal half of NSP4 have
een observed previously in attenuated rotavirus strains.
n the attenuated human rotavirus vaccine strain, 89-12,
here is a single substitution in NSP4 at amino acid 45
Ward et al., 1997), and in the attenuated Wa strain there
re three mutations in the amino-terminal 34 residues of
he protein (Chang et al., 1999). However, in neither strain
as the attenuated phenotype been linked to mutations
n NSP4. An amino acid substitution from asparagine to
istidine at residue 47 in SA11 NSP4 has been shown to
nhance the cytotoxic activity of the protein (Tian et al.,
000). The SA11 strain used in this study, as well as each
f the SA11 isolates from persistent infection, has a
istidine at residue 47. Therefore, in the context of rota-
irus infection, it appears that residues that influence
oxicity of the protein are not altered.
Why would mutations in NPS4 target distinctly differ-
nt regions during stable expression and persistent in-
ection? NSP4 is a potent cytotoxin (Newton et al., 1997)
nd enterotoxin (Ball et al., 1996; Zhang et al., 1998). In
ddition to its hypothesized involvement in rotavirus
athogenesis, NSP4 also plays a critical role in rotavirus
eplication. NSP4 acts as an intracellular receptor for the
otavirus double-layered particle, which is a requisite
ntermediate in rotavirus assembly. During viral morpho-
enesis, the carboxy-terminal tail of NSP4 transfers dou-
le-layered particles into the endoplasmic reticulum
here outercapsid proteins VP4 and VP7 coalesce onto
hese particles to form mature triple-layered virion prog-
ny (Au et al., 1989; Estes, 1996; Taylor et al., 1996). To
serve its function in rotavirus replication, NSP4 must
interact with several rotavirus proteins, which might limit
the types of mutations that the protein can tolerate. In
support of this idea, mutations in NSP4 in some rotavirus
strains are associated with concomitant changes in VP4
and VP7 (Kirkwood et al., 1996). Therefore, it is possible
that constraints imposed on NSP4 by its functions in
rotavirus replication limit mutations to the amino-terminal
half of the protein. It is also possible that other rotavirus
proteins suppress the cytotoxic activities of NSP4. Such
suppression would presumably allow the virus to com-
plete its replication cycle prior to the premature death of
host cells. There are precedents in other virus familiesfor just such relationships. For example, during baculo-
virus infections, apoptosis mediated by one viral protein
(p33) is inhibited by another viral protein (p35) (Ahmad et
al., 1997; Grigori et al., 1999). Therefore, it is possible that
the cytotoxic activities of NSP4 when expressed de novo
in cells are inhibited when the protein is expressed
during viral infection. In this scenario, NSP4 would not
act as a toxin and, therefore, mutations in NSP4 cytotoxic
domains would not be selected.
In contrast to the types of mutations selected in NSP4
during persistent infection, constitutive expression of
NSP4 in the absence of viral infection would likely lead to
selection of mutations in regions of the protein associ-
ated with cytotoxicity. Such mutations would be antici-
pated to be free of constraints imposed by interactions
with other rotavirus proteins, including putative interac-
tions that might mask cytotoxic effects. Our results sug-
gest that such mutations target the carboxy-terminal half
of NSP4 and in fact select a single residue previously
shown to be important for NSP4-mediated enterotoxic
activities (Zhang et al., 1998). Therefore, the selection of
mutations in discrete regions of NSP4 appears to be
dependent on whether the protein is expressed in the
presence or absence of other viral proteins during viral
infection.
Results reported here suggest that mutations are se-
lected in both amino- and carboxy-terminal regions of
NSP4 during its expression in cells. However, only those
in the amino-terminal half of the protein appear to be
tolerated in the context of rotavirus replication. Our on-
going studies of the functional ramifications of sequence
changes in NSP4 selected in different biological contexts
will enhance an understanding of viral cytotoxins and
potentially contribute to the development of rotavirus
vaccines.
MATERIALS AND METHODS
Cells and viruses
Human rotavirus strain Wa, simian rotavirus strain
SA11, MA104 cells, and Caco-2 cells were obtained from
the American Type Culture Collection (Manassas, VA).
Virus infection of cells was performed as previously
described (Casola et al., 1998). MA104 cells were in-
fected with either parental rotavirus strains or superna-
tant stocks derived from MA104 cell cultures persistently
infected with either Wa or SA11 as previously described
(Mrukowicz et al., 1998). Supernatants were obtained
from persistently infected MA104 cell cultures at various
intervals for these experiments.
Construction of plasmids for eukaryotic expression of
NSP4 with an HA epitope tagTotal cellular RNA was isolated from virus-infected
cells according to the protocol described by Atreya et al.
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131MUTATIONS IN ROTAVIRUS ENTEROTOXIN NSP4(1998). Using a pair of rotavirus NSP4 gene termini-
specific forward (59GGCTTTTAAAAGTTCTGTTC 39,
primer 1) and reverse (59GGTCACACTAAGACCATTCCT
39, primer 2) primers, a copy of the full-length NSP4-
encoding gene was amplified by reverse transcription
(RT) and polymerase chain reaction (PCR) as previously
described (Atreya et al., 1998; Forng and Atreya, 1999).
The PCR-amplified NSP4-encoding cDNA fragment was
cloned into mammalian expression plasmid pCR3.1 (TA-
unidirectional cloning vector with a CMV RNA polymer-
ase promoter, Invitrogen, Carlsbad, CA), and the com-
plete nucleotide sequence of this cDNA was determined
by dideoxy chain termination using ABI prism dye termi-
nator reaction mix (PE Applied Biosystems, Warrington,
UK) (GenBank Accession Number AF200224). This plas-
mid was used as a template for subsequent rounds of
PCR amplification.
Two versions of the NSP4 open reading frame (ORF), a
translation initiation codon deleted version (NSP4–
DATG) and an influenza virus hemagglutinin epitope-
tagged version (NSP4–HA), were amplified by PCR and
cloned into pCR3.1 at NheI and XhoI sites. The resultant
plasmids were designated pCR–NSP4–DATG and pCR–
NSP4–HA, respectively (Fig. 1). The NSP4–DATG con-
struct was amplified by using a forward primer with an
NheI restriction site and lacking the ATG codon (DATG)
(59AGCGCTAGCGATAAGCTTGCCGACC 39, primer 3) and
a reverse primer corresponding to primer 2 appended
with an XhoI restriction site (primer 4). The NSP4–HA
version of the cDNA was amplified by using reverse
primer 4 and a forward primer (59AGCGCTAGCATGGCT-
TACCCATACGATGTTCCAGATTACGCCTCGTTGGGTGGT-
ATGGATAAGCTTGCCGACCTC 39, primer 5) that included
the coding sequence for an ATG-fused 15-amino-acid HA
epitope and 7-amino-acid NSP4 ORF sequence with a 59
NheI restriction site. The amplified PCR products and
pCR3.1 DNA were digested with NheI and XhoI, and the
cDNAs were ligated into the plasmid.
Detection of NSP4 following in vitro translation
Plasmid constructs pCR–NSP4, pCR–NSP4–HA, and
pCR–NSP4–DATG were used as a template to generate
[35S]methionine proteins using a coupled transcription
nd translation system according to the manufacturer’s
nstructions (Promega, Madison, WI). Proteins were im-
unoprecipitated using an HA-epitope-specific mono-
lonal antibody (Santa Cruz Biotecnology, Santa Cruz,
A) and resolved in a 15% polyacrylamide gel as previ-
usly described (Singh et al., 1994).
ransfection of NSP4-encoding plasmid DNA into
aco-2 cells for constitutive expressionCaco-2 cells were grown in 100-mm disposable petri
lates containing Dulbecco’s modified Eagle’s medium cGibco-BRL, Gaithersburg, MD) supplemented to contain
0% fetal calf serum (HyClone Laboratories, Logan, UT),
% L-glutamine, 100 units of penicillin/ml, and 50 mg of
streptomycin/ml (Gibco-BRL). DNA transfections were
performed using Lipofectin reagent to introduce PvuI-
linearized plasmid DNA into subconfluent cells accord-
ing to the manufacturer’s instructions (Gibco-BRL). Inde-
pendently prepared plasmid DNAs for each construct
were used in separate transfections, which were desig-
nated experiment I and experiment II. After transfection,
cells were maintained in medium containing 200 mg of
G418 sulfate/ml (Geneticin, Gibco-BRL) until cell foci
were visible. Individual cell foci were maintained in me-
dium containing 200 mg of G418/ml.
Detection of NSP4-encoding RNA
Total cellular RNA was isolated from G418-resistant cell
foci selected after transfection with either pCR–NSP4–
DATG or pCR–NSP4–HA plasmid DNA. Rotavirus NSP4-
specific RNA was detected by RT-PCR using isolated cel-
lular RNA as a template. Primers 3 and 4 were used for
amplification of DNA corresponding to the NSP4–DATG
sequence, and primers 4 and 5 were used for amplification
of DNA corresponding to the NSP4–HA sequence.
Detection of NSP4 protein expression in cells
NSP4–HA was detected by immunoblot analysis using a
monoclonal antibody specific for the HA epitope (Santa
Cruz Biotechnology, Inc.) and by immunoprecipitation using
NSP4-specific monoclonal antibody B4-2 (kindly provided
by Dr. Greenberg, Stanford, CA). For immunoblots, total
cellular proteins were collected from cells after lysis in
phosphate-buffered saline, pH 7.0. Sample volume equiva-
lent to 30 mg of protein was collected from each lysate and
resolved in a 15% polyacrylamide gel (Singh et al., 1994).
After electrophoresis, gels were electroblotted onto nitro-
cellulose membranes and immunoblotted using the HA-
specific monoclonal antibody. Reaction products were de-
tected using chemiluminescence (Pierce Inc., Rockford, IL).
For immunoprecipitation, cells were radiolabeled with
[35S]methionine, and proteins were collected from cells af-
er lysis in phosphate-buffered saline, pH 7.0. NSP4 was
mmunoprecipitated as previously described (Forng and
rey, 1995) using NSP4-specific monoclonal antibody B4-2.
mmune complexes containing radiolabeled proteins were
esolved in 15% polyacrylamide gels. After electrophoresis,
els were dried onto filter paper and subjected to autora-
iography.
ucleotide sequence analysis of NSP4-encoding
DNAs recovered by RT-PCR from NSP4-expressing
ells and cells persistently infected with rotavirusTotal cellular RNA was isolated from G418-resistant
ell foci selected after transfection with either pCR–
a
c
B
Z
132 KRISHNA MOHAN, DERMODY, AND ATREYANSP4–DATG or pCR–NSP4–HA plasmid DNA. The RNA
was subjected to NSP4-specific RT-PCR using primers 3
and 4 for amplification of DNA corresponding to the
NSP4–DATG sequence and primers 4 and 5 for amplifi-
cation of DNA corresponding to the NSP4–HA sequence.
Nucleotide sequences of NSP4-encoding cDNAs were
determined by dideoxy chain termination sequencing.
These sequences were compared to NSP4-encoding se-
quences of the parental Wa and SA11 strains, which
were amplified by RT-PCR using a pair of forward
and reverse primers, common to Wa and SA11 NSP4
ORFs (forward: 59GGCTTTTAAAAGTTCTGTTC39; re-
verse: 59GGTCACACTAAGACCATTCCT39). One micro-
gram of purified plasmid DNA or 200 ng of PCR product
DNA in a volume of 20 ml was mixed with 100 ng of the
ppropriate primer. One microliter of DMSO (5%, final
oncentration) and 8 ml of ABI prism dye terminator
reaction mix were added to the reaction. The reaction
mixture was subjected to dye-terminator cycle sequenc-
ing in a GenAmp PCR system 9600 (Perkin–Elmer, Foster
City, CA), using the protocol 25 cycles at 96°C for 30 s,
50°C for 15 s, and 60°C for 4 min (PE Applied Biosys-
tems). Reaction products were precipitated in 95% etha-
nol, washed with 70% ethanol, air-dried, and analyzed
using an automated sequencer (Perkin–Elmer PE-ABI
Prism 377).
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